Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity

Despite the robust immunogenicity of SARS-CoV-2 mRNA vaccines, emerging data have revealed enhanced neutralizing antibody and T cell cross-reactivity among individuals that previously experienced COVID-19, pointing to a hybrid immune advantage with infection-associated immune priming. Beyond neutral...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowman, Kathryn A., Stein, Daniel, Shin, Sally, Ferbas, Kathie G., Tobin, Nicole H., Mann, Colin, Fischinger, Stephanie, Ollmann Saphire, Erica, Lauffenburger, Douglas, Rimoin, Anne W., Aldrovandi, Grace, Alter, Galit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600672/
https://www.ncbi.nlm.nih.gov/pubmed/36000735
http://dx.doi.org/10.1128/mbio.01647-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600672/
https://www.ncbi.nlm.nih.gov/pubmed/36000735
http://dx.doi.org/10.1128/mbio.01647-22

Ejemplares similares